Logo

American Heart Association

  108
  0


Final ID: 4147426

Intravascular Lithotripsy vs Rotational Atherectomy in Calcified Left Main Coronary Artery Disease: A Systematic Review and Meta-analysis

Abstract Body (Do not enter title and authors here): Background: Calcified left main disease is a high-risk and procedurally complex subset of coronary artery disease. So, adequate lesion preparation before stenting is crucial in achieving a favorable outcome. We performed a meta-analysis to compare the safety of intravascular lithotripsy (IVL) and rotational atherectomy (RA) in preparation of calcified left main coronary artery disease.

Hypothesis: We hypothesize that there are no significant differences in angiographic and in-hospital outcomes between RA and IVL while treating calcified left main coronary disease.

Methods: We systematically searched PubMed, Embase, and Cochrane databases until May 2024 for studies comparing IVL and RA in calcified left main coronary disease. A random-effects model was used to pool risk ratios (RR) with corresponding 95% confidence intervals (CI). Statistical analyses were performed using software R and heterogeneity was assessed using I2 statistics.

Results: We included 3 studies comprising 276 patients undergoing PCI for calcified left main disease, of whom 109 (39.5%) underwent lesion preparation with IVL. The mean age was 72.9 years and 73.1% were males. In the pooled analysis, there were no significant differences between the IVL and RA treated groups in terms of in-hospital mortality (RR 0.30; 95% CI 0.08 to 1.13, p=0.07, I2=0%; Figure 1A) and in-hospital myocardial infarction (RR 0.85; 95% CI 0.17 to 4.11, p=0.83, I2=0%; Figure 1B). There was also no significant difference in angiographic outcomes such as coronary perforation (RR 0.56; 95% CI 0.15 to 2.04; p=0.37, I2=0%; Figure 2A) and slow-flow/no-reflow (RR 1.43; 95% CI 0.22 to 9.51; p=0.70, I2=0%; Figure 2B).

Conclusion: This meta-analysis showed that both IVL and RA were comparable in terms of in-hospital and angiographic outcomes while treating calcified left main coronary disease.
  • Lingamsetty, Shanmukh Sai Pavan  ( Mamata Medical College , Khammam , India )
  • Thyagaturu, Harshith  ( West Virginia University , Morgantown , West Virginia , United States )
  • Santer, Matthew  ( West Virginia University , Morgantown , West Virginia , United States )
  • Abugrin, Mohamed  ( Bassett Medical Center , Cooperstown , New York , United States )
  • Awad, Maan  ( West Virginia University , Morgantown , West Virginia , United States )
  • Padala, Vikram  ( Lewis Katz School of Medicine at Temple University , Philadelphia , Pennsylvania , United States )
  • Saifuddin, Mohammed  ( West Virginia University , Morgantown , West Virginia , United States )
  • Author Disclosures:
    Shanmukh sai pavan Lingamsetty: DO NOT have relevant financial relationships | Harshith Thyagaturu: DO NOT have relevant financial relationships | Matthew Santer: DO NOT have relevant financial relationships | Mohamed Abugrin: DO NOT have relevant financial relationships | Maan Awad: DO NOT have relevant financial relationships | Vikram Padala: No Answer | Mohammed Saifuddin: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts from these authors:
Comparative Cardiac Safety of Bruton Tyrosine Kinase Inhibitors: A Bayesian Network Meta-Analysis

Kritya Mangesh, Solipuram Vinod Kumar Reddy, Thyagaturu Harshith, Lingamsetty Shanmukh Sai Pavan, Maurya Priyanshi, Doma Mohamed, Jitta Sahas Reddy, Awad Maan, Ramadan Adham, Lawrence Alexander Santhi Jaison, Cherukuri Anjani Mahesh Kumar

Outcomes of Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes and Heart Failure with Preserved Ejection Fraction: A Retrospective Cohort Analysis

Murshid Abdulrahman, Awad Maan, Ahmad Syed, Alawad Saud, Thyagaturu Harshith

You have to be authorized to contact abstract author. Please, Login
Not Available